Frankfurt - Delayed Quote EUR

Akebia Therapeutics, Inc. (AX9.F)

Compare
2.2020
-0.0420
(-1.87%)
At close: January 24 at 8:02:39 AM GMT+1
All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-38,501.0000
-23,384.0000
-73,154.0000
-252,965.0000
-110,388.0000
Investing Cash Flow
-31.0000
--
-114.0000
39,941.0000
-40,004.0000
Financing Cash Flow
26,048.0000
-25,206.0000
14,598.0000
133,731.0000
231,720.0000
End Cash Position
35,693.0000
44,579.0000
93,169.0000
151,839.0000
231,132.0000
Interest Paid Supplemental Data
--
6,059.0000
6,755.0000
9,632.0000
7,843.0000
Capital Expenditure
--
--
-114.0000
-59.0000
-317.0000
Issuance of Capital Stock
27,264.0000
6,793.0000
7,531.0000
88,948.0000
210,519.0000
Issuance of Debt
--
--
--
--
19,975.0000
Repayment of Debt
-45,100.0000
-32,000.0000
-33,000.0000
--
--
Free Cash Flow
-38,532.0000
-23,384.0000
-73,268.0000
-253,024.0000
-110,705.0000
12/31/2020 - 4/1/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers